Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

GMO Debate Delivers Blow to European Biotech Assessment

June 11, 2008

By Peter O'Donnell

European Parliament Seeks Urgent Debate on Biotech

June 4, 2008

By Peter O'Donnell

European Parliament Ponders its Biobanking Resources

May 21, 2008

By Peter O'Donnell

Commission GMO Debate Achieves No Resolution

May 14, 2008

By Peter O'Donnell

Europe Starts New Review of Biotech Approval Rules

May 7, 2008

By Peter O'Donnell

European Biotech Goes Back to Back on Meetings

April 30, 2008

By Peter O'Donnell

European Biotech Industry Plunges Into Energy Debate

April 23, 2008

By Peter O'Donnell

New Warnings of Funding Famine For EU Biotech

April 16, 2008

By Peter O'Donnell

European Agency Focuses on Processing Therapies Faster

April 9, 2008

By Peter O'Donnell

Another EU Administrative Approval for a GM Crop

April 2, 2008

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...